cholecystitis
Conditions
Interventions
Observation group:Intravenous injection of 0.25mg/kg esketamine 30min before peeling
Control group:Intravenous injection of 0.9%NS 30min before peeling
Sponsors
The Second Affiliated Hospital, School of Medicine, The Chinese University of Hong Kong, Shenzhen & Longgang District People’s Hospital of Shenzhen
Eligibility
Sex/Gender
All
Age
18 Years to 65 Years
Inclusion criteria
Inclusion criteria: 1. Age 18~65 years old; 2. ASA grade 1~2; 3. Laparoscopic cholecystectomy in general surgery.
Exclusion criteria
Exclusion criteria: 1. History of hypertension, coronary heart disease, or abnormal cardiopulmonary function, severe liver and kidney function; 2. Recent history of analgesic and sedative drugs, and history of narcotic analgesic drug addiction or drug use.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Numerical Rating Scale; | — |
Secondary
| Measure | Time frame |
|---|---|
| Ramsay Sedation Scale;Ramsay Sedation Scale;Tracheal catheter removal time;Incidence of adverse reactions; | — |
Countries
China
Contacts
Public ContactZhu Qiuyu
The Second Affiliated Hospital, School of Medicine, The Chinese University of Hong Kong, Shenzhen & Longgang District People’s Hospital of Shenzhen
Outcome results
None listed